BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17407483)

  • 1. Haemolysis alters plasma flecainide levels in newborn infants.
    Vento M; Tudela BF; Escrig R; Sáenz P; Sánchez A; Cano A
    Acta Paediatr; 2007 Mar; 96(3):466-8. PubMed ID: 17407483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flecainide as first-line treatment for supraventricular tachycardia in newborns.
    Ferlini M; Colli AM; Bonanomi C; Salvini L; Galli MA; Salice P; Ravaglia R; Centola M; Danzi GB
    J Cardiovasc Med (Hagerstown); 2009 May; 10(5):372-5. PubMed ID: 19300276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of flecainide in the preventive treatment of tachycardia crisis of Wolff-Parkinson-White syndrome in 4 newborn infants].
    Lupoglazoff JM; Jacqz-Aigrain E; Denjoy I; Casasoprana A
    Arch Fr Pediatr; 1991 Nov; 48(9):627-9. PubMed ID: 1763931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal flecainide toxicity following supraventricular tachycardia treatment.
    Hall CM; Ward Platt MP
    Ann Pharmacother; 2003 Sep; 37(9):1343-4. PubMed ID: 12921523
    [No Abstract]   [Full Text] [Related]  

  • 5. Supraventricular tachycardia resistant to treatment in a pregnant woman.
    Treakle K; Kostic B; Hulkower S
    J Fam Pract; 1992 Nov; 35(5):581-4. PubMed ID: 1431774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of supraventricular tachycardia with flecainide acetate: a case report.
    Amano K; Harada Y; Shoda T; Nishijima M; Hiraishi S
    Fetal Diagn Ther; 1997; 12(6):328-31. PubMed ID: 9475360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for the use of flecainide in patients with supraventricular arrhythmias.
    Smith W; Crozier I; McAlister H; O'Meeghan T; Stewart F
    N Z Med J; 2000 Oct; 113(1119):420-1. PubMed ID: 11127360
    [No Abstract]   [Full Text] [Related]  

  • 8. [Interactions of quinidine and propranolol with mexiletine, encainide, flecainide and tocainide].
    Halawa B
    Pol Tyg Lek; 1990 Mar 5-12; 45(10-11):222-4. PubMed ID: 2120685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [European protocol for the management of fetal supraventricular tachycardia. European Association of Pediatric Cardiology].
    Azancot-Benisty A; Areias JC; Oberhänsli I; Schmidt KG; Tulzer G; Viart P
    Arch Mal Coeur Vaiss; 1997 May; 90(5):735-43. PubMed ID: 9295960
    [No Abstract]   [Full Text] [Related]  

  • 10. Fetal and maternal magnetocardiography during flecainide therapy for supraventricular tachycardia.
    Campbell JQ; Best TH; Eswaran H; Lowery CL
    Obstet Gynecol; 2006 Sep; 108(3 Pt 2):767-71. PubMed ID: 17018496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When potion becomes poison! A case report of flecainide toxicity.
    Bajaj S; Tullu MS; Khan Z; Agrawal M
    J Postgrad Med; 2017; 63(4):265-267. PubMed ID: 28272074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supraventricular tachycardia with hydrops in a 27-week premature baby.
    Abraham P
    Int J Clin Pract; 2001 Oct; 55(8):569-70. PubMed ID: 11695082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal ECG changes caused by supratherapeutic flecainide following treatment for fetal supraventricular tachycardia.
    Rasheed A; Simpson J; Rosenthal E
    Heart; 2003 Apr; 89(4):470. PubMed ID: 12639886
    [No Abstract]   [Full Text] [Related]  

  • 14. Gender-associated differences in pharmacokinetics and anti-arrhythmic effects of flecainide in Japanese patients with supraventricular tachyarrhythmia.
    Doki K; Homma M; Kuga K; Aonuma K; Sakai S; Yamaguchi I; Kohda Y
    Eur J Clin Pharmacol; 2007 Oct; 63(10):951-7. PubMed ID: 17665182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of flecainide in critical neonates and infants with incessant supraventricular tachycardias.
    Ergül Y; Özyılmaz İ; Saygı M; Tola HT; Akdeniz C; Tuzcu V
    Turk Kardiyol Dern Ars; 2015 Oct; 43(7):607-12. PubMed ID: 26536985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory Fetal Supraventricular Tachycardia with Hydrops Successfully Converted by Intraperitoneal Flecainide in the Fetus: A Case Report.
    Vedel C; Vejlstrup N; Jensen LN; Ekelund CK; Nørgaard LN; Harmsen L; Petersen OB; Jaeggi E; Gembruch U; Sundberg K
    Fetal Diagn Ther; 2020; 47(9):717-720. PubMed ID: 32570238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A symposium: Supraventricular Arrhythmias: Update 1995. Boston, Massachusetts, May 6, 1995.
    Am J Cardiol; 1996 Jan; 77(3):1A-95A. PubMed ID: 8607386
    [No Abstract]   [Full Text] [Related]  

  • 18. An enhancement of coronary blood flow in a fetus with supraventricular tachycardia.
    Uerpairojkit B; Manotaya S; Tanawattanacharoen S; Prechawat S; Charoenvidhya D
    Prenat Diagn; 2009 Mar; 29(3):274-6. PubMed ID: 19165830
    [No Abstract]   [Full Text] [Related]  

  • 19. [Protocols for the treatment of supraventricular tachycardias in the fetus].
    Oudijk MA; Ambachtsheer EB; Stoutenbeek P; Meijboom EJ
    Ned Tijdschr Geneeskd; 2001 Jun; 145(25):1218-9. PubMed ID: 11447879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis, treatment, observation and outcome of fetal supraventricular tachycardia in a twin pregnancy.
    Schiermeier S; van Leeuwen P; Reinhard J; Gronemeyer D; Hatzmann W
    Fetal Diagn Ther; 2008; 24(4):327-30. PubMed ID: 18836269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.